We are live on ! Find out more
OCDX

Ortho Clinical Diagnostics Holdings

Delisted

OCDX was delisted on the 26th of May, 2022.

106 hedge funds and large institutions have $4.95B invested in Ortho Clinical Diagnostics Holdings in 2021 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

55,957% more call options, than puts

Call options by funds: $7.85M | Put options by funds: $14K

75% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 16

12% more funds holding

Funds holding: 95 → 106 (+11)

0% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 36

8% less capital inflows, than outflows

Capital inflows: $210M | Capital outflows: $228M

1.01% less ownership

Funds ownership: 99.72% → 98.71% (-1%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
106
Holders Change
+11
Holders Change %
+11.58%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
28
Increased
36
Reduced
36
Closed
16
Calls
$7.85M
Puts
$14K
Net Calls
+$7.83M
Net Calls Change
+$1.94M

OCDX Hedge Fund Activity: Q2 2021 in Review

106 of the 5,771 institutional investors tracked by Wall St. Rank reported a position in Ortho Clinical Diagnostics Holdings (OCDX) for Q2 2021, worth a combined $4.95B — up 9.6% from $4.52B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new OCDX positions and 16 closed out — a net gain of 12 holders — while 36 added to existing stakes and 36 trimmed.

The largest buyer was Macquarie Group, opening a new position worth an estimated $29.8M. The largest seller was Alyeska Investment Group, cutting an estimated $45.7M.

  • 106 institutional investors held Ortho Clinical Diagnostics Holdings (OCDX) as of Q2 2021, up from 95 in Q1 2021.
  • Funds reported $4.95B of Ortho Clinical Diagnostics Holdings stock for Q2 2021, up 9.6% quarter-over-quarter.
  • 28 funds opened new Ortho Clinical Diagnostics Holdings positions in Q2 2021 and 16 closed out, a net change of +12 holders.
  • The largest Ortho Clinical Diagnostics Holdings buyer in Q2 2021 was Macquarie Group, an estimated $29.8M added.
  • The largest Ortho Clinical Diagnostics Holdings seller in Q2 2021 was Alyeska Investment Group, an estimated $45.7M sold.

Based on aggregated 13F filings for Q2 2021.